Scientists have found a way to 'intercept' pancreatic cancer. By inhibiting the cancer gene FGFR2, they were able to slow tumor formation. By targeting the FGFR2 and EGFR proteins, they were able to ...

While CRC is on the rise in people under 50, receiving colonoscopies beginning at age 45 can help decrease your risk.

Pat Gulhati, MD, PhD, discusses findings from a comprehensive analysis of genetic, immunological, and signaling pathway variations in pancreatic cancer.

Precancerous pancreatic lesions and some pancreatic ductal adenocarcinoma (PDAC) tumors harboring KRAS mutations had ...

“Cancer doesn’t just affect the person, it affects the family.” Pifani visited several doctors and they agreed he had Stage 3, inoperable pancreatic cancer. The tumor encased part of the ...

According to the results, PAC-MANN was 85% sensitive for detecting stage 1 PDAC, and 96% accurate for ruling out healthy controls. First author Jose Montoya Mira said: “Our test could be used for ...

Pancreatic cancer is projected to become the second-deadliest cancer by 2030. By the time it's diagnosed, it's often ...

Little progress has been made on the treatment of advanced pancreatic ... cancer and comparing gemcitabine-based combination chemotherapy with gemcitabine alone, the hazard ratio (HR < 1 ...

A vaccine kept patients free of pancreatic cancer for years, yet new reports say the NIH is advising against mentioning mRNA tech in grants.

Progress. The Wall Street Journal’s Brianna Abbott reports that a tragically slim 3 percent of late-stage pancreatic cancer patients survive. The numbers are horrifying, which means we can hope ...

Adding immunotherapy to new KRAS inhibitors boosted responses in preclinical models, setting the stage for ... forms of the cancer-causing gene mutation KRAS kept pancreatic cancer at bay in ...